These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11666011)

  • 1. Cyclin D1 expression in normal oligodendroglia and microglia cells: its use in the differential diagnosis of oligodendrogliomas.
    Bosone I; Cavalla P; Chiadò-Piat L; Vito ND; Schiffer D
    Neuropathology; 2001 Sep; 21(3):155-61. PubMed ID: 11666011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative chromatin pattern description in Feulgen-stained nuclei as a diagnostic tool to characterize the oligodendroglial and astroglial components in mixed oligo-astrocytomas.
    Decaestecker C; Lopes BS; Gordower L; Camby I; Cras P; Martin JJ; Kiss R; VandenBerg SR; Salmon I
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):391-402. PubMed ID: 9100670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokeratin immunoreactivity in gliomas.
    Ng HK; Lo ST
    Histopathology; 1989 Apr; 14(4):359-68. PubMed ID: 2472343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trk A, B, and C are commonly expressed in human astrocytes and astrocytic gliomas but not by human oligodendrocytes and oligodendroglioma.
    Wang Y; Hagel C; Hamel W; Müller S; Kluwe L; Westphal M
    Acta Neuropathol; 1998 Oct; 96(4):357-64. PubMed ID: 9797000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
    Geiger KD; Stoldt P; Schlote W; Derouiche A
    Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors in oligodendrogliomas in humans.
    Fiano V; Ghimenti C; Schiffer D
    Neurosci Lett; 2003 Aug; 347(2):111-5. PubMed ID: 12873740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.
    Rousseau A; Nutt CL; Betensky RA; Iafrate AJ; Han M; Ligon KL; Rowitch DH; Louis DN
    J Neuropathol Exp Neurol; 2006 Dec; 65(12):1149-56. PubMed ID: 17146289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunocytochemical comparison of glial fibrillary acidic protein, S-100p and vimentin in human glial tumors.
    Nakopoulou L; Kerezoudi E; Thomaides T; Litsios B
    J Neurooncol; 1990 Feb; 8(1):33-40. PubMed ID: 2319288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
    Shukla B; Agarwal S; Suri V; Pathak P; Sharma MC; Gupta D; Sharma BS; Suri A; Halder A; Sarkar C
    Neurol India; 2009; 57(5):559-66. PubMed ID: 19934553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Native Oligodendrocytes in Astrocytomas Might Inhibit Tumor Proliferation by WIF1 Expression.
    Asslaber M; Schauer S; Gogg-Kamerer M; Bernhart E; Quehenberger F; Haybaeck J
    J Neuropathol Exp Neurol; 2017 Jan; 76(1):16-26. PubMed ID: 28040794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases.
    Machen SK; Prayson RA
    Hum Pathol; 1998 Dec; 29(12):1511-6. PubMed ID: 9865840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
    Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
    Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
    Ligon KL; Alberta JA; Kho AT; Weiss J; Kwaan MR; Nutt CL; Louis DN; Stiles CD; Rowitch DH
    J Neuropathol Exp Neurol; 2004 May; 63(5):499-509. PubMed ID: 15198128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells.
    Bouvier C; Bartoli C; Aguirre-Cruz L; Virard I; Colin C; Fernandez C; Gouvernet J; Figarella-Branger D
    J Neurosurg; 2003 Aug; 99(2):344-50. PubMed ID: 12924709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 expression in gliomas.
    Cavalla P; Dutto A; Piva R; Richiardi P; Grosso R; Schiffer D
    Acta Neuropathol; 1998 Feb; 95(2):131-5. PubMed ID: 9498046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma.
    Herpers MJ; Budka H
    Acta Neuropathol; 1984; 64(4):265-72. PubMed ID: 6391068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of cyclin D1 and alpha-internexin in oligodendroglial tumors.
    Matsumura N; Nobusawa S; Ikota H; Hirato J; Hirose T; Yokoo H; Nakazato Y
    Brain Tumor Pathol; 2015 Oct; 32(4):261-7. PubMed ID: 26233522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
    Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
    J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.